PNT
Income statement / Annual
Last year (2022), POINT Biopharma Global Inc.'s total revenue was $226.58 M,
and the percentage change from the previous year is not available.
In 2022, POINT Biopharma Global Inc.'s net income was $98.29 M.
See POINT Biopharma Global Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$226.58 M |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$226.58 M
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
1
|
0
|
0
|
0
|
| Research and Development Expenses |
$82.05 M
|
$33.51 M
|
$9.14 M
|
$1,160.00
|
| General & Administrative Expenses |
$19.01 M
|
$12.01 M
|
$3.97 M
|
$27,720.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$7,236.00
|
| Selling, General & Administrative Expenses |
$19.01 M
|
$12.01 M
|
$3.97 M
|
$34,956.00
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$101.06 M
|
$45.51 M
|
$13.11 M
|
$36,896.00
|
| Cost And Expenses |
$101.06 M
|
$45.51 M
|
$13.11 M
|
$36,896.00
|
| Interest Income |
$4.47 M
|
$11,840.00
|
$5,354.00
|
$0.00
|
| Interest Expense |
$0.00
|
$11,840.00
|
$5,354.00
|
$0.00
|
| Depreciation & Amortization |
$1.80 M
|
$11,840.00
|
$206,297.00
|
$171,860.00
|
| EBITDA |
$127.32 M |
-$45.51 M |
-$13.11 M |
-$780.00 |
| EBITDA Ratio |
0.56
|
0
|
0
|
0
|
| Operating Income Ratio |
0.55
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$4.06 M
|
-$84,993.00
|
-$170,316.00
|
-$780.00
|
| Income Before Tax |
$129.59 M
|
-$45.60 M
|
-$13.29 M
|
-$36,896.00
|
| Income Before Tax Ratio |
0.57
|
0
|
0
|
0
|
| Income Tax Expense |
$31.29 M
|
$305,658.00
|
$87,882.00
|
-$780.00
|
| Net Income |
$98.29 M
|
-$45.90 M
|
-$13.37 M
|
-$36,896.00
|
| Net Income Ratio |
0.43
|
0
|
0
|
0
|
| EPS |
1.04 |
-0.62 |
-0.34 |
0 |
| EPS Diluted |
1.02 |
-0.62 |
-0.34 |
0 |
| Weighted Average Shares Out |
$94.60 M
|
$73.85 M
|
$38.88 M
|
$0.00
|
| Weighted Average Shares Out Diluted |
$96.03 M
|
$73.85 M
|
$38.88 M
|
$0.00
|
| Link |
|
|
|
|
